NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel total assets
Total assets on the balance sheet at the end of each period.
Nexgel's total assets was $26.45M at Jun 30, 2026. For fiscal 2025 it was $10.46M, down 4.8% from the year before. The highest annual figure on record is $16.98M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.46M | -4.8% |
| FY2024 | Dec 31, 2024 | $10.98M | +10.3% |
| FY2023 | Dec 31, 2023 | $9.96M | -3.9% |
| FY2022 | Dec 31, 2022 | $10.36M | -39.0% |
| FY2021 | Dec 31, 2021 | $16.98M | +652.5% |
| FY2020 | Dec 31, 2020 | $2.26M | +19.4% |
| FY2019 | Dec 31, 2019 | $1.89M | +155.8% |
| FY2018 | Dec 31, 2018 | $739.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $26.45M | +172.3% |
| Q1 FY2026 | Mar 31, 2026 | $11.60M | +11.1% |
| Q4 FY2025 | Dec 31, 2025 | $10.46M | -4.8% |
| Q3 FY2025 | Sep 30, 2025 | $11.62M | +9.9% |
| Q2 FY2025 | Jun 30, 2025 | $9.71M | -0.7% |
| Q1 FY2025 | Mar 31, 2025 | $10.44M | +0.5% |
| Q4 FY2024 | Dec 31, 2024 | $10.98M | +10.3% |
| Q3 FY2024 | Sep 30, 2024 | $10.57M | +6.3% |
| Q2 FY2024 | Jun 30, 2024 | $9.78M | -6.9% |
| Q1 FY2024 | Mar 31, 2024 | $10.39M | -5.6% |
| Q4 FY2023 | Dec 31, 2023 | $9.96M | -3.9% |
| Q3 FY2023 | Sep 30, 2023 | $9.95M | -11.5% |
| Q2 FY2023 | Jun 30, 2023 | $10.50M | -23.8% |
| Q1 FY2023 | Mar 31, 2023 | $11.01M | -21.8% |
| Q4 FY2022 | Dec 31, 2022 | $10.36M | -39.0% |
| Q3 FY2022 | Sep 30, 2022 | $11.23M | +127.4% |
| Q2 FY2022 | Jun 30, 2022 | $13.77M | +235.1% |
| Q1 FY2022 | Mar 31, 2022 | $14.08M | +311.0% |
| Q4 FY2021 | Dec 31, 2021 | $16.98M | +652.5% |
| Q3 FY2021 | Sep 30, 2021 | $4.94M | +124.2% |
| Q2 FY2021 | Jun 30, 2021 | $4.11M | +81.9% |
| Q1 FY2021 | Mar 31, 2021 | $3.43M | +75.2% |
| Q4 FY2020 | Dec 31, 2020 | $2.26M | +19.4% |
| Q3 FY2020 | Sep 30, 2020 | $2.20M | +35.3% |
| Q2 FY2020 | Jun 30, 2020 | $2.26M | +24.9% |
| Q1 FY2020 | Mar 31, 2020 | $1.96M | +164.5% |
| Q4 FY2019 | Dec 31, 2019 | $1.89M | – |
| Q3 FY2019 | Sep 30, 2019 | $1.63M | – |
| Q2 FY2019 | Jun 30, 2019 | $1.81M | – |
| Q4 FY2018 | Dec 31, 2018 | $739.00K | – |